Repositório PUCRS
metadata only
Interação entre o receptor purinérgico P2X7 e a interleucina-17 em linhagens de glioma humano
Glioblastoma multiforme (GBM) is the most aggressive tumor of the CNS and most deadly primary tumors. Despite the malignant gliomas are generally treated with radiotherapy, often they exhibit a significant radioresistance that limits the treatment success. It can be postulated that molecular changes
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety Study of MGD009 in B7-H3-expressing Tumors#894828
- Clinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM Personalised Vaccine in Patients With Newly Diagnosed Glioma.#127594
- A Phase I/IIa Study of Cerebraca Wafer Plus Adjuvant Temozolomide (TMZ) in Patients With Recurrent High Grade Glioma#841671
- Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma#1032450
- Study of Tinostamustine for Adjuvant Treatment of Glioblastoma#994628
Record · ID 946115
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive